{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:08:36Z","timestamp":1784297316257,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,17]]},"DOI":"10.7759\/cureus.112854","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:59:56Z","timestamp":1784296796000},"source":"Crossref","is-referenced-by-count":0,"title":["Retrospective Analysis of Adverse Drug Reactions From a Teaching Hospital in South India: Patterns, Severity, Causality, and Preventability"],"prefix":"10.7759","author":[{"given":"Sirpy","family":"Ram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandabaskar","family":"Nishanthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanthi","family":"Manickam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shravan","family":"Venkatraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Safety of medicines. a guide to detecting and reporting adverse drug reactions: why health professionals need to take action. (2002). Accessed: March 11, 2026: https:\/\/www.who.int\/publications\/i\/item\/WHO-EDM-QSM-2002-2."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2174\/1574886310666150921104523","article-title":"Incidence of adverse drug reactions in Indian hospitals: a systematic review of prospective studies","volume":"11","author":"Patel TK","year":"2016","unstructured":"Patel TK, Patel PB. Incidence of adverse drug reactions in Indian hospitals: a systematic review of prospective studies. Curr Drug Saf. 2016, 11:128-36. 10.2174\/1574886310666150921104523","journal-title":"Curr Drug Saf"},{"key":"ref3","unstructured":"What is pharmacovigilance?. Accessed. March 11, 2026: https:\/\/www.who.int\/teams\/regulation-prequalification\/regulation-and-safety\/pharmacovigilance."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2012.53.5.1022","article-title":"Spontaneous reporting of adverse drug reactions through electronic submission from regional society healthcare professionals in Korea","volume":"53","author":"Lee JH","year":"2012","unstructured":"Lee JH, Park KH, Moon HJ, Lee YW, Park JW, Hong CS. Spontaneous reporting of adverse drug reactions through electronic submission from regional society healthcare professionals in Korea. Yonsei Med J. 2012, 53:1022-7. 10.3349\/ymj.2012.53.5.1022","journal-title":"Yonsei Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-021-01520-y","article-title":"An OMOP-CDM based pharmacovigilance data-processing pipeline (PDP) providing active surveillance for ADR signal detection from real-world data sources","volume":"21","author":"Shin H","year":"2021","unstructured":"Shin H, Lee S. An OMOP-CDM based pharmacovigilance data-processing pipeline (PDP) providing active surveillance for ADR signal detection from real-world data sources. BMC Med Inform Decis Mak. 2021, 21:10.1186\/s12911-021-01520-y","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-052737","article-title":"Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study","volume":"11","author":"Sharma M","year":"2021","unstructured":"Sharma M, Baghel R, Thakur S, Adwal S. Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study. BMJ Open. 2021, 11:10.1136\/bmjopen-2021-052737","journal-title":"BMJ Open"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/18826.8284","article-title":"A retrospective analysis of reporting of adverse drug reactions in a tertiary care teaching hospital: one year survey","volume":"10","author":"Pathak AK","year":"2016","unstructured":"Pathak AK, Kumar M, Dokania S, Mohan L, Dikshit H. A retrospective analysis of reporting of adverse drug reactions in a tertiary care teaching hospital: one year survey. J Clin Diagn Res. 2016, 10:1-4. 10.7860\/JCDR\/2016\/18826.8284","journal-title":"J Clin Diagn Res"},{"key":"ref8","unstructured":"Indian Pharmacopoeia Commission. annual performance report. Accessed: March 11, 2026: https:\/\/www.ipc.gov.in\/mandates\/pvpi\/publications\/8-category-en\/646-annual-performance-report.html."},{"key":"ref9","unstructured":"The use of the WHO-UMC system for standardised case causality assessment. Accessed. March 11, 2026: https:\/\/www.who.int\/docs\/default-source\/medicines\/pharmacovigilance\/whocausality-assessment.pdf."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/cmrp.cmrp_107_21","article-title":"Characterisation of seriousness and outcome of adverse drug reactions in patients received cancer chemotherapy drugs - a prospective observational study","volume":"12","author":"Fatmi SM","year":"2022","unstructured":"Fatmi SM, Bagati, KD, Dutta S, Sharma J. Characterisation of seriousness and outcome of adverse drug reactions in patients received cancer chemotherapy drugs - a prospective observational study. Curr Med Res Pract. 2022, 12:20-5. 10.4103\/cmrp.cmrp_107_21","journal-title":"Curr Med Res Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/49.9.2229","article-title":"Preventability and severity assessment in reporting adverse drug reactions","volume":"49","author":"Hartwig SC","year":"1992","unstructured":"Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992, 49:2229-32. 10.1093\/ajhp\/49.9.2229","journal-title":"Am J Hosp Pharm"},{"key":"ref12","article-title":"Focusing on the preventability of adverse drug reactions","volume":"27","author":"Schumock GT","year":"1992","unstructured":"Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992, 27:","journal-title":"Hosp Pharm"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-023-01302-7","article-title":"Factors associated with underreporting of adverse drug reactions by health care professionals: a systematic review update","volume":"46","author":"Garc\u00eda-Abeijon P","year":"2023","unstructured":"Garc\u00eda-Abeijon P, Costa C, Taracido M, Herdeiro MT, Torre C, Figueiras A. Factors associated with underreporting of adverse drug reactions by health care professionals: a systematic review update. Drug Saf. 2023, 46:625-36. 10.1007\/s40264-023-01302-7","journal-title":"Drug Saf"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.150344","article-title":"Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India","volume":"47","author":"Tandon VR","year":"2015","unstructured":"Tandon VR, Mahajan V, Khajuria V, Gillani Z. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India. Indian J Pharmacol. 2015, 47:65-71. 10.4103\/0253-7613.150344","journal-title":"Indian J Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/2050-6511-14-5","article-title":"Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil","volume":"14","author":"Lobo MG","year":"2013","unstructured":"Lobo MG, Pinheiro SM, Castro JG, Moment\u00e9 VG, Pranchevicius MC. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil. BMC Pharmacol Toxicol. 2013, 14:10.1186\/2050-6511-14-5","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2018.0393","article-title":"Frequent adverse drug reactions, and medication groups under suspicion: a descriptive analysis based on spontaneous reports to the German Federal Institute for Drugs and Medical Devices from 1978-2016","volume":"115","author":"Dubrall D","year":"2018","unstructured":"Dubrall D, Schmid M, Ale\u0161ik E, Paeschke N, Stingl J, Sachs B. Frequent adverse drug reactions, and medication groups under suspicion: a descriptive analysis based on spontaneous reports to the German Federal Institute for Drugs and Medical Devices from 1978-2016. Dtsch Arztebl Int. 2018, 115:393-400. 10.3238\/arztebl.2018.0393","journal-title":"Dtsch Arztebl Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2019.10.001","article-title":"Reported adverse drug reactions in women and men: aggregated evidence from globally collected individual case reports during half a century","volume":"17","author":"Watson S","year":"2019","unstructured":"Watson S, Caster O, Rochon PA, den Ruijter H. Reported adverse drug reactions in women and men: aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine. 2019, 17:10.1016\/j.eclinm.2019.10.001","journal-title":"EClinicalMedicine"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/picr.PICR_64_17","article-title":"An analysis of adverse drug reactions in extremes of age group at tertiary care teaching hospital","volume":"9","author":"Amin S","year":"2018","unstructured":"Amin S, Shah S, Desai M, Shah A, Maheriya KM. An analysis of adverse drug reactions in extremes of age group at tertiary care teaching hospital. Perspect Clin Res. 2018, 9:70-5. 10.4103\/picr.PICR_64_17","journal-title":"Perspect Clin Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-017-0186-x","article-title":"Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients","volume":"18","author":"V\u00e1zquez-Alvarez AO","year":"2017","unstructured":"V\u00e1zquez-Alvarez AO, Brennan-Bourdon LM, Rinc\u00f3n-S\u00e1nchez AR, Islas-Carbajal MC, Huerta-Olvera SG. Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients. BMC Pharmacol Toxicol. 2017, 18:10.1186\/s40360-017-0186-x","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13306","article-title":"Adverse drug reactions spontaneously reported at a tertiary care hospital and preventable measures implemented","volume":"46","author":"Esba LC","year":"2021","unstructured":"Esba LC, Al Mardawi G, AlJasser MI, Aljohani B, Alburak AA. Adverse drug reactions spontaneously reported at a tertiary care hospital and preventable measures implemented. J Clin Pharm Ther. 2021, 46:460-9. 10.1111\/jcpt.13306","journal-title":"J Clin Pharm Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_831_21","article-title":"Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions","volume":"10","author":"Shukla AK","year":"2021","unstructured":"Shukla AK, Jhaj R, Misra S, Ahmed SN, Nanda M, Chaudhary D. Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions. J Family Med Prim Care. 2021, 10:3303-8. 10.4103\/jfmpc.jfmpc_831_21","journal-title":"J Family Med Prim Care"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/2229-3485.192044","article-title":"An analysis of serious adverse drug reactions at a tertiary care teaching hospital","volume":"7","author":"Prajapati K","year":"2016","unstructured":"Prajapati K, Desai M, Shah S, Panchal J, Kapadia J, Dikshit R. An analysis of serious adverse drug reactions at a tertiary care teaching hospital. Perspect Clin Res. 2016, 7:181-6. 10.4103\/2229-3485.192044","journal-title":"Perspect Clin Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajme.2018.10.005","article-title":"Analysis and reporting of adverse drug reactions at a tertiary care teaching hospital","volume":"54","author":"Venkatasubbaiah M","year":"2018","unstructured":"Venkatasubbaiah M, Dwarakanadha RP, Satyanarayana SV. Analysis and reporting of adverse drug reactions at a tertiary care teaching hospital. Alexandria J Med. 2018, 54:597-603. 10.1016\/j.ajme.2018.10.005","journal-title":"Alexandria J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-015-2002-1","article-title":"Adverse drug reactions in hospitalized pediatric patients: a prospective observational study","volume":"83","author":"Kurian J","year":"2016","unstructured":"Kurian J, Mathew J, Sowjanya K, Chaitanya KR, Ramesh M, Sebastian J, Narayanappa D. Adverse drug reactions in hospitalized pediatric patients: a prospective observational study. Indian J Pediatr. 2016, 83:414-9. 10.1007\/s12098-015-2002-1","journal-title":"Indian J Pediatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2025.100615","article-title":"Adverse drug reactions in persons initiated on treatment for drug-resistant tuberculosis in Kerala, India: a non-concurrent cohort study","volume":"15","author":"Vaman RS","year":"2025","unstructured":"Vaman RS, Thomas GD, Kalyanasundaram M, Soman S, Valamparampil MJ, Susheela RP, Murhekar MV. Adverse drug reactions in persons initiated on treatment for drug-resistant tuberculosis in Kerala, India: a non-concurrent cohort study. IJID Reg. 2025, 15:10.1016\/j.ijregi.2025.100615","journal-title":"IJID Reg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/506694-retrospective-analysis-of-adverse-drug-reactions-from-a-teaching-hospital-in-south-india-patterns-severity-causality-and-preventability","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:59:58Z","timestamp":1784296798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/506694-retrospective-analysis-of-adverse-drug-reactions-from-a-teaching-hospital-in-south-india-patterns-severity-causality-and-preventability"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.112854","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}